While the actual opportunity for FTX6058 will remain a point of interest the lifting of the clinical hold marks an important win for the new management team and instills confidence they can right a ship that has undergone a series of mishapsadversities wrote Stifel analyst Dae Gon Ha in a note to investors on Tuesday